Nasdaq stocks posting largest percentage decreases
AP - Thu Aug 14, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
NewLink Genetics: Ready to test Ebola vaccine
By TOM MURPHY - AP - Thu Aug 14, 3:25PM CDT
An Iowa drug developer is preparing to test a possible Ebola vaccine in humans, as scientists race to develop ways to prevent or fight a virus that has killed more than 1,000 people in a West African outbreak.
Drug Approvals & Updates, Licensing Agreements, and Upcoming Conferences - Research Reports on Tekmira, MannKind, Eli Lilly, GSK and Cigna
PR Newswire - Thu Aug 14, 7:30AM CDT
Today, Analysts Review released its research reports regarding Tekmira Pharmaceuticals Corp. (NASDAQ: TKMR), MannKind Corp. (NASDAQ: MNKD), Eli Lilly and Company (NYSE: LLY), GlaxoSmithKline PLC (NYSE: GSK) and Cigna Corp. (NYSE: CI). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5727-100free.
IIROC Trade Resumption - Tekmira Pharmaceuticals Corporation
Newsfile Corp - Thu Aug 14, 7:21AM CDT
Trading resumes in:
'Fast Money' Recap: Some Good, Some Bad for Cisco
at The Street - Thu Aug 14, 4:00AM CDT
The trading panel looked at Cisco's latest earnings and whether Macy's stock should be bought now.
Business Highlights
By The Associated Press - AP - Wed Aug 13, 5:19PM CDT
___
Drugmaker not ready to use Ebola drug in Africa
By MATTHEW PERRONE - AP - Wed Aug 13, 5:06PM CDT
WASHINGTON (AP) — A Canadian drugmaker working on an experimental drug for Ebola said Wednesday that it is not ready to make the treatment available in Africa, despite assurances by international health officials that it is ethical to use untested treatments to fight the deadly outbreak.
Tekmira Provides Corporate Update and Announces Second Quarter 2014 Results
GlobeNewswire - Wed Aug 13, 3:30PM CDT
Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, today announced its financial and operating results for the second quarter ended June 30, 2014 and provided a corporate update.
Today's Dead Cat Bounce Stock: Tekmira Pharmaceuticals (TKMR)
at The Street - Wed Aug 13, 9:26AM CDT
Trade-Ideas LLC identified Tekmira Pharmaceuticals (TKMR) as a "dead cat bounce" (down big yesterday but up big today) candidate
Nasdaq stocks posting largest volume increases
AP - Tue Aug 12, 5:11PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
1 Comment
Most active Nasdaq-traded stocks
AP - Tue Aug 12, 5:11PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
Kate Spade and Flowers Foods are big market movers
AP - Tue Aug 12, 3:42PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:
Tekmira Shares Continue to Rise in the Search for Ebola Cure - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 12, 3:20PM CDT
Shares of Tekmira (TKMR) rose for the second successive day following the FDA announcement on TKM-Ebola.
Potential Payoffs Spur Big Board Biotech Action
ACCESSWIRE - Tue Aug 12, 2:03PM CDT
Los Angeles, CA / ACCESSWIRE / August 12, 2014 / Speculators were pushing certain big board biotechs higher as they placed their bets on potentially big future payoffs.